CareTrust REIT, Inc.
CTREReal EstateNASDAQREIT - Healthcare Facilities · Last scanned Sep 9, 2026
Scan Results
Daily timeframeHeadquartered within the real estate sector, CareTrust REIT, Inc. focuses on REIT - Healthcare Facilities services and products. CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related. The $9.29B market capitalization puts CTRE squarely in mid-cap range for its industry. With a portfolio of long-term net-leased properties spanning the United States and United Kingdom, and a growing portfolio of quality operators leasing them, CareTrust is pursuing both external and organic growth opportunities across the US and internationally.
Market Cap
$9.29B
Beta
0.79
P/E (TTM)
24.57
P/E (Fwd)
22.27
EPS (TTM)
$1.60
EPS (Fwd)
$1.77
ROE
9.1%
ROA
4.4%
Cash
$30.5M
Total Debt
$665.8M
Free CF
-$80.3M
52W Change
15.2%
Annual Financials
Cash vs Debt
Where CTRE stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CTRE finished 0.76% above its 150-day moving average ($39.27) and 2.94% above its 200-day moving average ($38.44). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CTRE overbought or oversold?
At the September 3, 2026 close, CTRE's RSI(14) was 59.2, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
CareTrust REIT, Inc. carries $665.8M in total debt against $30.5M in cash reserves — debt is roughly 21.9x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow is running at -$80.3M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of 9.1% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.4% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $187.5M (2022) to $369.4M (2025), reflecting a 97% increase over the period.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CTRE.